Aethlon Medical, Inc. (NASDAQ:AEMD – Get Free Report) saw a large drop in short interest in the month of September. Get Aethlon Medical alerts:Institutional Investors Weigh In On Aethlon MedicalAn institutional investor recently bought a new position in Aethlon Medical stock. Armistice Capital LLC owned 8.89% of Aethlon Medical as of its most recent filing with the Securities and Exchange Commission. The business has a fifty day moving average price of $1.14 and a 200 day moving average price of $2.03. Aethlon Medical Company Profile(Get Free Report)Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.